| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue | 4,222 | 5,019 |
-
| | | Gross Profit | (4,222) | (5,019) |
-
| | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 781 | 2,208 | 8,305 | | Non Recurring |
-
|
-
|
-
| | Others | 2 | 2 | 540 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (5,006) | (7,229) | (8,845) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (90) | 396 | 391 | | Earnings Before Interest And Taxes | (5,095) | (6,833) | (8,454) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (5,095) | (6,833) | (8,454) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,095) | (6,833) | (8,454) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (5,095) | (6,833) | (8,454) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,095) | ($6,833) | ($8,454) |
|
0.20% Nasdaq 
Income Statement
